Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

Correction: 'Liraglutide (VICTOZA): Add Another One to the List of "Do Not Use" Drugs for Type-2 Diabetes'

Worst Pills, Best Pills Newsletter article July, 2011

In our April 2011 Worst Pills, Best Pills News article about the inappropriately approved, dangerous new diabetes drug liraglutide (VICTOZA), there was an error in a paragraph describing interpretation of the results of the blood test hemoglobin A1c (HbA1c), which is used to assess the body’s control of sugar (glucose).

On page 5 of the newsletter, the last paragraph in the section entitled “The FDA’s approval of liraglutide” should have the following corrected last sentence:

"HbA1c is...

In our April 2011 Worst Pills, Best Pills News article about the inappropriately approved, dangerous new diabetes drug liraglutide (VICTOZA), there was an error in a paragraph describing interpretation of the results of the blood test hemoglobin A1c (HbA1c), which is used to assess the body’s control of sugar (glucose).

On page 5 of the newsletter, the last paragraph in the section entitled “The FDA’s approval of liraglutide” should have the following corrected last sentence:

"HbA1c is reported as a percentage, and it is now thought that a value between 7.0 and 7.5 percent is an acceptable goal, since higher [not lower] levels caused increases in overall mortality."